Unaltered plasma levels of β-amyloid(1-40) and β-amyloid(1-42) upon stimulation of human platelets

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 2, 2003, Pages 93-97

  Olsson, Annika ^a   Vanmechelen, Eugeen ^b   Vanderstichele, Hugo ^b   Davidsson, Pia ^a   Blennow, Kaj ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b INNOGENETICS   (Belgium)

Author keywords

Amyloid; Alzheimer's disease; ELISA; Plasma; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; COLLAGEN; PRESENILIN 1; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; BLOOD PLATELETS; ENDOPEPTIDASES; HUMANS; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PRESENILIN-1;

EID: 0037638938     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070681     Document Type: Article

References (33)

1. Glenner GG, Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890.
2. 1-42/43) of amyloid-β protein as a seed molecule in cerebral deposits of Alzheimer's disease. Biochem Biophys Res Commun 1994;205:834-842.
3. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-736.
4. Hooper NM, Karran EH, Turner AJ: Membrane protein secretases. Biochem J 1997;321:265-279.
5. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA: Evidence that tumor necrosis factor-α-converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 1998;273:27765-27767.
6. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F: Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 1999;96:3922-3927.
7. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M: β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-741.
8. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J: Human aspartic protease memapsin-2 cleaves the β-secretase site of β-amyloid precursor protein. Proc Natl Acad Sci USA 2000;97:1456-1460.
9. Li YM, Lai MT, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK, Shi XP, Yin KC, Shafer JA, Gardell SJ: Presenilin-1 is linked with γ-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 2000;97:6138-6143.
10. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D: Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-327.
11. 1-42 in cerebrospinal fluid and plasma. Amyloid 2000;7:245-258.
12. 42 and τ: Potential markers of Alzheimer's disease. J Neural Transm Suppl 1998;53:209-221.
13. 1-42 and τ levels in CSF. Neurology 1999;52:1555-1562.
14. 1-42(43) in Alzheimer's disease: A study in Japan. Ann Neurol 1998;44:17-26.
15. 1-42 and incipient Alzheimer's disease. Ann Neurol 1999;46:412-416.
16. Mehta PD, Pirttila T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM: Plasma and cerebrospinal fluid levels of amyloid-β proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 2000;57:100-105.
17. Tamaoka A, Fukushima T, Sawamura N, Ishikawa K, Oguni E, Komatsuzaki Y, Shoji S: Amyloid-β protein in plasma from patients with sporadic Alzheimer's disease. J Neurol Sci 1996;141:65-68.
18. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD: Platelet protease nexin-2/amyloid-β protein precursor. Possible pathologic and physiologic functions. Ann NY Acad Sci 1991;640:140-144.
19. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters CL: The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990;265:15977-15983.
20. Chen M, Inestrosa NC, Ross GS, Fernandez HL: Platelets are the primary source of amyloid-β peptide in human blood. Biochem Biophys Res Commun 1995;213:96-103.
21. Li QX, Whyte S, Tanner JE, Evin G, Beyreuther K, Masters CL: Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets. Lab Invest 1998;78:461-469.
22. Skovronsky DM, Lee VM, Pratico D: Amyloid precursor protein and amyloid-β peptide in human platelets. Role of cyclooxygenase and protein kinase C. J Biol Chem 2001;276:17036-17043.
23. Pastorino L, Colciaghi F, Marcon G, Borroni B, Cottini E, Cattabeni F, Padovani A, Di Luca M: Presenilin-2 mutation does not influence expression and concentration of APP forms in human platelets. Mol Med 2000;6:816-824.
24. Vidal R, Ghiso J, Wisniewski T, Frangione B: Alzheimer's presenilin-1 gene expression in platelets and megakaryocytes. Identification of a novel splice variant. FEBS Lett 1996;393:19-23.
25. Ludlam CA, Cash JD: Studies on liberation of β-thromboglobulin from human platelets in vitro. Br J Haematol 1976;33:239-247.
26. Whyte S, Wilson N, Currie J, Maruff P, Malone V, Shafiq-Antonacci R, Tyler P, Derry KL, Underwood J, Li Q-X, Beyreuther K, Masters CL: Collection and normal levels of the amyloid precursor protein in plasma. Ann Neurol 1997;41:121-124.
27. 42 secretion. Hum Mol Genet 1999;8:1529-1540.
28. Svennerholm L, Håkansson G, Månsson J-E, Nilsson O: Chemical differentiation of the Gaucher subtypes. Prog Clin Biol Res 1982;95:231-252.
29. Davidsson P, Blennow K: Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int Psychogeriatr 1998;10:11-23.
30. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia SS: Endoproteolysis of presenilin-1 and accumulation of processed derivatives in vivo. Neuron 1996;17:181-190.
31. Leary JJ, Brigati DJ, Ward DC: Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc Natl Acad Sci USA 1983;80:4045-4049.
32. Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE: Amyloid-β peptides interact with plasma proteins and erythrocytes: Implications for their quantitation in plasma. Biochem Biophys Res Commun 2000;268:750-756.
33. Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ: Amyloid-β peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 1996;271:32916-32922.